We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-17.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
-$1.36B
(-19%)
Cap. Flow
-$72.7M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
17.58%
Holding
1,139
New
165
Increased
376
Reduced
380
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$58.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$27.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$23.3M |
| 4 |
TJX Companies
TJX
|
+$23.1M |
| 5 |
Synopsys
SNPS
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$45.2M |
| 2 |
Rockwell Automation
ROK
|
+$25.3M |
| 3 |
Accenture
ACN
|
+$24M |
| 4 |
Visteon
VC
|
+$23.4M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.85% |
| 2 | Financials | 17.71% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
HUB Group
HUBG
$3.01B
| $4.66M | 0.08% |
251,538
-31,288
| -11% | -$671K |
|
|
PRA
277
DELISTED
ProAssurance
PRA
| $4.64M | 0.08% |
114,498
+9,952
| +10% | +$427K |
|
|
CSII
278
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.63M | 0.08% |
162,593
+18,160
| +13% | +$577K |
|
|
GHDX
279
DELISTED
Genomic Health, Inc.
GHDX
| $4.63M | 0.08% |
71,867
-73,626
| -51% | -$5.16M |
|
280
CoreCivic
CXW
$3.1B
| $4.62M | 0.08% |
258,968
+127,755
| +97% | +$2.81M |
|
281
AT&T
T
$165B
| $4.61M | 0.08% |
213,907
+137,564
| +180% | +$3.2M |
|
282
Astronics
ATRO
$3.45B
| $4.61M | 0.08% |
181,592
+56,205
| +45% | +$1.48M |
|
283
NVR
NVR
$17.2B
| $4.59M | 0.08% |
1,885
-5
| -0.3% | -$11.8K |
|
|
INFN
284
DELISTED
Infinera Corporation Common Stock
INFN
| $4.58M | 0.08% |
1,148,983
+266,000
| +30% | +$1.33M |
|
|
FLOW
285
DELISTED
SPX FLOW, Inc.
FLOW
| $4.56M | 0.08% |
149,937
+82,778
| +123% | +$3.12M |
|
|
AXE
286
DELISTED
Anixter International Inc
AXE
| $4.53M | 0.08% |
83,467
+15,380
| +23% | +$968K |
|
287
Theravance Biopharma
TBPH
$874M
| $4.47M | 0.08% |
174,743
+4,080
| +2% | +$110K |
|
288
RingCentral
RNG
$4.05B
| $4.41M | 0.08% |
53,502
-8,530
| -14% | -$672K |
|
289
Yelp
YELP
$1.38B
| $4.4M | 0.08% |
125,720
+7,890
| +7% | +$301K |
|
290
Par Pacific Holdings
PARR
$3.88B
| $4.39M | 0.08% |
309,754
+63,586
| +26% | +$1.08M |
|
|
KRA
291
DELISTED
Kraton Corporation
KRA
| $4.39M | 0.08% |
201,097
-2,370
| -1% | -$69.5K |
|
292
Eagle Bancorp
EGBN
$867M
| $4.34M | 0.08% |
89,131
-49,908
| -36% | -$2.54M |
|
|
FIT
293
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $4.33M | 0.08% |
871,114
+69,600
| +9% | +$359K |
|
294
Hyster-Yale Materials Handling
HY
$593M
| $4.32M | 0.08% |
69,692
-830
| -1% | -$51.7K |
|
295
Rapid7
RPD
$634M
| $4.28M | 0.08% |
137,300
-2,410
| -2% | -$78.9K |
|
296
Burlington
BURL
$22B
| $4.27M | 0.08% |
26,257
-79,807
| -75% | -$12.9M |
|
297
Pacira BioSciences
PCRX
$1.02B
| $4.27M | 0.08% |
+99,289
| New | +$4.63M |
|
298
Devon Energy
DVN
$51.9B
| $4.19M | 0.07% |
185,900
+66,950
| +56% | +$2.06M |
|
|
AMTD
299
DELISTED
TD Ameritrade Holding Corp
AMTD
| $4.19M | 0.07% |
85,490
-33,690
| -28% | -$1.72M |
|
300
CF Industries
CF
$19.2B
| $4.17M | 0.07% |
95,914
-43,700
| -31% | -$2.05M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2018 Portfolio in Review
As of Q4 2018, Jacobs Levy Equity Management held 1,139 positions worth $5.69B, down 19% from $7.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2018 filing shows 165 new, 376 increased, 380 reduced and 175 closed positions. Its largest new stake was Starbucks: 930,980 shares worth $60M. The largest sale was Dell, an estimated $45.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2018 buy was Starbucks: 930,980 shares worth $60M.
- Jacobs Levy Equity Management added most to Celgene Corp in Q4 2018, an estimated $27.6M increase.
- Jacobs Levy Equity Management's biggest Q4 2018 reduction was Accenture, cutting an estimated $24M.
- Jacobs Levy Equity Management fully exited Dell in Q4 2018, selling an estimated $45.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $5.69B portfolio in Q4 2018.
- Jacobs Levy Equity Management opened 165 new positions and closed 175 in Q4 2018.
- Jacobs Levy Equity Management's portfolio value fell 19% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2018, filed 14 Feb 2019.